Literature DB >> 30548475

Memory CD4+ T cells enhance B-cell responses to drifting influenza immunization.

Emily Gage1,2, Neal Van Hoeven1,2,3, Natasha Dubois Cauwelaert1, Sasha E Larsen1, Jesse Erasmus1, Mark T Orr1,2, Rhea N Coler1,2,3.   

Abstract

Influenza A annually infects 5-10% of the world's human population resulting in one million deaths. Influenza causes annual epidemics and reinfects previously exposed individuals because of antigenic drift in the glycoprotein hemagglutinin. Due to antigenic drift, the immune system is simultaneously exposed to novel and conserved parts of the influenza virus via vaccination and/or infection throughout life. Preexisting immunity has long been known to augment subsequent hemagglutination inhibitory antibody (hAb) responses. However, the preexisting immunological contributors that influence hAb responses are not understood. Therefore, we adapted and developed sequential infection and immunization mouse models using drifted influenza strains to show that MHC Class II haplotype and T-cell reactivity influences subsequent hAb responses. We found that CB6F1 mice infected with A/CA followed by immunization with A/PR8 have increased hAb responses to A/PR8 compared to C57BL/6 mice. Increased hAb responses in CB6F1 mice were CD4+  T-cell and B-cell dependent and corresponded to increased germinal center A/PR8-specific B and T-follicular helper cells. These results suggest conserved MHC Class II restricted epitopes within HA are essential for B cells to respond to drifting influenza and could be leveraged to boost hAb responses.
© 2018 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  infectious diseases; influenza; preexisting immunity; vaccinology

Year:  2018        PMID: 30548475      PMCID: PMC6494461          DOI: 10.1002/eji.201847852

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  60 in total

1.  Protection against influenza virus infection in polymeric Ig receptor knockout mice immunized intranasally with adjuvant-combined vaccines.

Authors:  Yasuko Asahi; Tomoki Yoshikawa; Izumi Watanabe; Takuya Iwasaki; Hideki Hasegawa; Yuko Sato; Shin-ichiro Shimada; Masanobu Nanno; Yoshiaki Matsuoka; Makoto Ohwaki; Yoichiro Iwakura; Yujiro Suzuki; Chikara Aizawa; Tetutaro Sata; Takeshi Kurata; Shin-ichi Tamura
Journal:  J Immunol       Date:  2002-03-15       Impact factor: 5.422

2.  Ab and T cell epitopes of influenza A virus, knowledge and opportunities.

Authors:  Huynh-Hoa Bui; Bjoern Peters; Erika Assarsson; Innocent Mbawuike; Alessandro Sette
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-02       Impact factor: 11.205

3.  Time for T?: Thoughts about the 2009 novel H1N1 influenza outbreak and the role of T cell epitopes in the next generation of influenza vaccines.

Authors:  Anne S De Groot; Elizabeth McClaine; Lenny Moise; William Martin
Journal:  Hum Vaccin       Date:  2010-02-19

4.  CD4 T cell-mediated protection from lethal influenza: perforin and antibody-mediated mechanisms give a one-two punch.

Authors:  Deborah M Brown; Allison M Dilzer; Dana L Meents; Susan L Swain
Journal:  J Immunol       Date:  2006-09-01       Impact factor: 5.422

5.  Eight-plasmid system for rapid generation of influenza virus vaccines.

Authors:  Erich Hoffmann; Scott Krauss; Daniel Perez; Richard Webby; Robert G Webster
Journal:  Vaccine       Date:  2002-08-19       Impact factor: 3.641

Review 6.  Influenza: old and new threats.

Authors:  Peter Palese
Journal:  Nat Med       Date:  2004-12       Impact factor: 53.440

Review 7.  Influenza virus still surprises.

Authors:  Jonathan Yewdell; Adolfo García-Sastre
Journal:  Curr Opin Microbiol       Date:  2002-08       Impact factor: 7.934

8.  Safety, efficacy, and immunogenicity of an inactivated influenza vaccine in healthy adults: a randomized, placebo-controlled trial over two influenza seasons.

Authors:  Lisa A Jackson; Manjusha J Gaglani; Harry L Keyserling; John Balser; Nancy Bouveret; Louis Fries; John J Treanor
Journal:  BMC Infect Dis       Date:  2010-03-17       Impact factor: 3.090

9.  Original antigenic sin responses to influenza viruses.

Authors:  Jin Hyang Kim; Ioanna Skountzou; Richard Compans; Joshy Jacob
Journal:  J Immunol       Date:  2009-07-31       Impact factor: 5.422

10.  THE QUANTITATIVE DETERMINATION OF INFLUENZA VIRUS AND ANTIBODIES BY MEANS OF RED CELL AGGLUTINATION.

Authors:  G K Hirst
Journal:  J Exp Med       Date:  1942-01-01       Impact factor: 14.307

View more
  3 in total

1.  Better Epitope Discovery, Precision Immune Engineering, and Accelerated Vaccine Design Using Immunoinformatics Tools.

Authors:  Anne S De Groot; Leonard Moise; Frances Terry; Andres H Gutierrez; Pooja Hindocha; Guilhem Richard; Daniel Fredric Hoft; Ted M Ross; Amy R Noe; Yoshimasa Takahashi; Vinayaka Kotraiah; Sarah E Silk; Carolyn M Nielsen; Angela M Minassian; Rebecca Ashfield; Matt Ardito; Simon J Draper; William D Martin
Journal:  Front Immunol       Date:  2020-04-07       Impact factor: 7.561

2.  Chronic Viral Infection Promotes Efficient Germinal Center B Cell Responses.

Authors:  Bénédict Fallet; Yi Hao; Marianna Florova; Karen Cornille; Alba Verge de Los Aires; Giulia Girelli Zubani; Yusuf I Ertuna; Victor Greiff; Ulrike Menzel; Karim Hammad; Doron Merkler; Sai T Reddy; Jean-Claude Weill; Claude-Agnès Reynaud; Daniel D Pinschewer
Journal:  Cell Rep       Date:  2020-01-28       Impact factor: 9.423

3.  Remote immune processes revealed by immune-derived circulating cell-free DNA.

Authors:  Ilana Fox-Fisher; Sheina Piyanzin; Bracha Lea Ochana; Agnes Klochendler; Judith Magenheim; Ayelet Peretz; Netanel Loyfer; Joshua Moss; Daniel Cohen; Yaron Drori; Nehemya Friedman; Michal Mandelboim; Marc E Rothenberg; Julie M Caldwell; Mark Rochman; Arash Jamshidi; Gordon Cann; David Lavi; Tommy Kaplan; Benjamin Glaser; Ruth Shemer; Yuval Dor
Journal:  Elife       Date:  2021-11-29       Impact factor: 8.140

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.